Comparison and predictors of treatment adherence and remission among patients with schizophrenia treated with paliperidone palmitate or atypical oral antipsychotics in community behavioral health organizations
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-244X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Comparison and predictors of treatment adherence and remission among patients with schizophrenia treated with paliperidone palmitate or atypical oral antipsychotics in community behavioral health organizations ; volume:17 ; number:1 ; day:18 ; month:10 ; year:2017 ; pages:1-10 ; date:12.2017
BMC psychiatry ; 17, Heft 1 (18.10.2017), 1-10, 12.2017
- Schlagwort
-
Hirnkrankheit
Neuropsychiatrie
Nervenkrankheit
- Urheber
-
Anderson, Jeffrey P.
- Beteiligte Personen und Organisationen
-
Icten, Zeynep
Alas, Veronica
Benson, Carmela
Joshi, Kruti
SpringerLink (Online service)
- DOI
-
10.1186/s12888-017-1507-8
- URN
-
urn:nbn:de:1111-2017121313725
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:33 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Anderson, Jeffrey P.
- Icten, Zeynep
- Alas, Veronica
- Benson, Carmela
- Joshi, Kruti
- SpringerLink (Online service)
Ähnliche Objekte (12)
Costs and Resource Utilization Among Medicaid Patients with Schizophrenia Treated with Paliperidone Palmitate or Oral Atypical Antipsychotics
Atypical antipsychotics
Economic Impact in Medicaid Beneficiaries with Schizophrenia and Cardiometabolic Comorbidities Treated with Once-Monthly Paliperidone Palmitate vs. Oral Atypical Antipsychotics
Diabetes and atypical antipsychotics
Serum prolactin levels and sexual dysfunction in patients with schizophrenia treated with antipsychotics: comparison between aripiprazole and other atypical antipsychotics
Simultaneous prescribing of atypical antipsychotics, conventional antipsychotics and anticholinergics—a European study
Clinical pharmacology of atypical antipsychotics: an update
Early predictors of poor treatment response in patients with schizophrenia treated with atypical antipsychotics
A study of antioxidant activity in patients with schizophrenia taking atypical antipsychotics
Atypical antipsychotics in the treatment of schizophrenic patients
Diabetic control and atypical antipsychotics: a case report
Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
Costs and Resource Utilization Among Medicaid Patients with Schizophrenia Treated with Paliperidone Palmitate or Oral Atypical Antipsychotics
Atypical antipsychotics
Economic Impact in Medicaid Beneficiaries with Schizophrenia and Cardiometabolic Comorbidities Treated with Once-Monthly Paliperidone Palmitate vs. Oral Atypical Antipsychotics
Diabetes and atypical antipsychotics
Serum prolactin levels and sexual dysfunction in patients with schizophrenia treated with antipsychotics: comparison between aripiprazole and other atypical antipsychotics
Simultaneous prescribing of atypical antipsychotics, conventional antipsychotics and anticholinergics—a European study
Clinical pharmacology of atypical antipsychotics: an update
Early predictors of poor treatment response in patients with schizophrenia treated with atypical antipsychotics
A study of antioxidant activity in patients with schizophrenia taking atypical antipsychotics
Atypical antipsychotics in the treatment of schizophrenic patients
Diabetic control and atypical antipsychotics: a case report
Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
Costs and Resource Utilization Among Medicaid Patients with Schizophrenia Treated with Paliperidone Palmitate or Oral Atypical Antipsychotics
Atypical antipsychotics
Economic Impact in Medicaid Beneficiaries with Schizophrenia and Cardiometabolic Comorbidities Treated with Once-Monthly Paliperidone Palmitate vs. Oral Atypical Antipsychotics
Diabetes and atypical antipsychotics
Serum prolactin levels and sexual dysfunction in patients with schizophrenia treated with antipsychotics: comparison between aripiprazole and other atypical antipsychotics
Simultaneous prescribing of atypical antipsychotics, conventional antipsychotics and anticholinergics—a European study
Clinical pharmacology of atypical antipsychotics: an update
Early predictors of poor treatment response in patients with schizophrenia treated with atypical antipsychotics
A study of antioxidant activity in patients with schizophrenia taking atypical antipsychotics
Atypical antipsychotics in the treatment of schizophrenic patients
Diabetic control and atypical antipsychotics: a case report